Skip to content

Benjamin Krantz, MD/MBA

NPI 1154564243ActiveIndividual· Internal Medicine, Hematology & Oncology· New York, NY

Internal Medicine, Hematology & Oncology (MD/MBA) in New York, New York, trained at Tufts University School of Medicine (class of 2009). Part D covered 162 prescriptions written in 2024, 65% of them generic. Adaptive Biotechnologies Corporation reported $22.73 in payments in 2025, mostly food and beverage.

Overview

NPI1154564243
StatusActive
Entity typeIndividual
CredentialMD/MBA
Sole proprietorNo
NPI issuedApr 20, 2009
Last updated in NPPESOct 24, 2025
Certified by providerOct 24, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Hematology/Oncology (NY)

Part D prescriptions in 2024

Prescriptions (claims)162 · 194 30-day fills
Patients18
Total drug cost$192,518
Generic share65% of claims

Medicare sources and data years

Education and affiliations

Medical schoolTufts University School of Medicine
Graduation year2009
Medicare specialtyHematology/Oncology

Medical group

Hospital affiliations

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$22.73 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Adaptive Biotechnologies Corporation$22.731

What the 2025 payments were for

  • Food and Beverage$22.73 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other hematologist-oncologists in New York

All 399 hematologist-oncologists in New York · All hematologist-oncologists in New York